Telehealth-Supervised Resistance Training for Children With Cerebral Palsy
Reason given: The study was terminiated due to funding.
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Hunan Normal University
- Trial code
- NCT07061275
- Record updated
- 22 June 2026
- Original description
The goal of this clinical trial is to evaluate the feasibility and potential benefits of telehealth-supervised resistance training in ambulatory children aged 6 to 15 years with cerebral palsy (CP) classified as Gross Motor Function Classification System (GMFCS) levels I-III.Read full original descriptionShow less
Telehealth-Supervised Resistance Training to Improve Functional Capacity and Muscle Strength in Children With Cerebral Palsy: Protocol for a Single-Arm Intervention Study
The goal of this clinical trial is to evaluate the feasibility and potential benefits of telehealth-supervised resistance training in ambulatory children aged 6 to 15 years with cerebral palsy (CP) classified as Gross Motor Function Classification System (GMFCS) levels I-III.
The main questions it aims to answer are:
* Is a 12-week telehealth-delivered resistance training program feasible and acceptable for children with CP and their caregivers? * Can the program improve physical function and psychosocial well-being in this population?
Participants will:
* Take part in three 40-minute, live-streamed resistance training sessions each week for 12 weeks, using elastic bands, sandbag weights, and balance tools * Complete physical assessments before and after the program, including the 1-minute walk test, 10-meter walk test, 30-second sit-to-stand test, and Pediatric Balance Scale * Complete quality of life surveys using the Pediatric Quality of Life Inventory (PedsQL™ 3.0 CP Module) * Have caregivers complete a custom questionnaire about the cost and acceptability of the program
Inclusion: No history of heart disease or family history of heart disease; Children classified as GMFCS levels I, II, or III; Dependent on assistive mobility devices, such as wheelchairs or posture support walkers, for activities of daily living; Medically stable and able to sit upright for at least 30 minutes; Able to understand simple verbal or visual instructions.
Exclusion: Received botulinum toxin A injections for lower limb muscles within six months prior to baseline assessment; Implanted with an intrathecal baclofen pump, or has a history of lower limb-related orthopedic or neurosurgical interventions (such as tendon lengthening, osteotomy, or selective dorsal rhizotomy); Has uncontrolled epilepsy, severe cognitive impairment, or other comorbidities; Aged under 6 years or over 15 years.